Responses
Regular and young investigator award abstracts
Checkpoint blockade therapy
209 Preclinical mechanistic and clinical evaluation of the corticosteroid dexamethasone’s detrimental effects on immune checkpoint blockade in glioblastoma cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.